The Progression of Pathophysiology of Moyamoya Disease

被引:16
作者
Chen, Tongyu [1 ]
Wei, Wei [1 ,2 ]
Yu, Jin [1 ]
Xu, Shuangxiang [1 ]
Zhang, Jianjian [1 ]
Li, Xiang [1 ,2 ,3 ,5 ]
Chen, Jincao [1 ,4 ]
机构
[1] Wuhan Univ, Zhongnan Hosp, Dept Neurosurg, Wuhan, Hubei, Peoples R China
[2] Wuhan Univ, Zhongnan Hosp, Brain Res Ctr, Wuhan, Hubei, Peoples R China
[3] Wuhan Univ, Zhongnan Hosp, Sino Italian Ascula Brain Sci Joint Lab, Wuhan, Hubei, Peoples R China
[4] Wuhan Univ, Zhongnan Hosp, Dept Neurosurg, Donghu Rd 169, Wuhan 430000, Peoples R China
[5] Wuhan Univ, Brain Res Ctr, Dept Neurosurg, Sino Italian Ascula Brain Sci Joint Lab,Zhongnan H, Donghu Rd 169, Wuhan 430000, Peoples R China
基金
中国国家自然科学基金;
关键词
Angiogenesis; Genetics; Inflammation; Moyamoya disease; Pathogenesis; ENDOTHELIAL GROWTH-FACTOR; SPONTANEOUS OCCLUSION; CEREBROSPINAL-FLUID; MATRIX METALLOPROTEINASES; ANGIOGENIC FACTORS; RNF213; VARIANTS; CELLS; PREVALENCE; EXPRESSION; WILLIS;
D O I
10.1227/neu.0000000000002455
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Moyamoya disease (MMD) is a chronic steno-occlusive cerebrovascular disease that often leads to hemorrhagic and ischemic strokes; however, its etiology remains elusive. Surgical revascularization by either direct or indirect bypass techniques to restore cerebral hypoperfusion is the treatment of choice to date. This review aims to provide an overview of the current advances in the pathophysiology of MMD, including the genetic, angiogenic, and inflammatory factors related to disease progression. These factors may cause MMD-related vascular stenosis and aberrant angiogenesis in complex manners. With a better understanding of the pathophysiology of MMD, nonsurgical approaches that target the pathogenesis of MMD may be able to halt or slow the progression of this disease.
引用
收藏
页码:502 / 509
页数:8
相关论文
共 84 条
  • [11] Pathological Circulating Factors in Moyamoya Disease
    Fang, Yao-Ching
    Wei, Ling-Fei
    Hu, Chaur-Jong
    Tu, Yong-Kwang
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (04) : 1 - 12
  • [12] Increased expression of serum matrix metalloproteinase-9 in patients with moyamoya disease
    Fujimura, Miki
    Watanabe, Mika
    Narisawa, Ayumi
    Shimizu, Hiroaki
    Tominaga, Teiji
    [J]. SURGICAL NEUROLOGY, 2009, 72 (05): : 476 - 480
  • [13] Periventricular anastomosis in moyamoya disease: detecting fragile collateral vessels with MR angiography
    Funaki, Takeshi
    Takahashi, Jun C.
    Yoshida, Kazumichi
    Takagi, Yasushi
    Fushimi, Yasutaka
    Kikuchi, Takayuki
    Mineharu, Yohei
    Okada, Tomohisa
    Morimoto, Takaaki
    Miyamoto, Susumu
    [J]. JOURNAL OF NEUROSURGERY, 2016, 124 (06) : 1766 - 1772
  • [14] Clinical and radiological recurrence after childhood arterial ischemic stroke
    Ganesan, Vijeya
    Prengler, Mara
    Wade, Angela
    Kirkham, Fenella J.
    [J]. CIRCULATION, 2006, 114 (20) : 2170 - 2177
  • [15] Modifiable Risk Factors Associated With Moyamoya Disease A Case-Control Study
    Ge, Peicong
    Zhang, Qian
    Ye, Xun
    Liu, Xingju
    Deng, Xiaofeng
    Wang, Jia
    Wang, Rong
    Zhang, Yan
    Zhang, Dong
    Zhao, Jizong
    [J]. STROKE, 2020, 51 (08) : 2472 - 2479
  • [16] Rare RNF213 variants in the C-terminal region encompassing the RING-finger domain are associated with moyamoya angiopathy in Caucasians
    Guey, Stephanie
    Kraemer, Markus
    Herve, Dominique
    Ludwig, Thomas
    Kossorotoff, Manoelle
    Bergametti, Francoise
    Schwitalla, Jan Claudius
    Choi, Simone
    Broseus, Lucile
    Callebaut, Isabelle
    Genin, Emmanuelle
    Tournier-Lasserve, Elisabeth
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2017, 25 (08) : 995 - 1003
  • [17] Mutations in Smooth Muscle Alpha-Actin (ACTA2) Cause Coronary Artery Disease, Stroke, and Moyamoya Disease, Along with Thoracic Aortic Disease
    Guo, Dong-Chuan
    Papke, Christina L.
    Tran-Fadulu, Van
    Regalado, Ellen S.
    Avidan, Nili
    Johnson, Ralph Jay
    Kim, Dong H.
    Pannu, Hariyadarshi
    Willing, Marcia C.
    Sparks, Elizabeth
    Pyeritz, Reed E.
    Singh, Michael N.
    Dalman, Ronald L.
    Grotta, James C.
    Marian, Ali J.
    Boerwinkle, Eric A.
    Frazier, Lorraine Q.
    LeMaire, Scott A.
    Coselli, Joseph S.
    Estrera, Anthony L.
    Safi, Hazim J.
    Veeraraghavan, Sudha
    Muzny, Donna M.
    Wheeler, David A.
    Willerson, James T.
    Yu, Robert K.
    Shete, Sanjay S.
    Scherer, Steven E.
    Raman, C. S.
    Buja, L. Maximilian
    Milewicz, Dianna M.
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2009, 84 (05) : 617 - 627
  • [18] Han W., 2020, MEDIATORS INFLAMM, V2020, P1
  • [19] An epidemiological survey of moyamoya disease, unilateral moyamoya disease and quasi-moyamoya disease in Japan
    Hayashi, Kentaro
    Horie, Nobutaka
    Suyama, Kazuhiko
    Nagata, Izumi
    [J]. CLINICAL NEUROLOGY AND NEUROSURGERY, 2013, 115 (07) : 930 - 933
  • [20] Critical role of platelet-derived growth factor-α in angiogenesis after indirect bypass in a murine moyamoya disease model
    Hayashi, Tomohide
    Yamamoto, Seiji
    Hamashima, Takeru
    Mori, Hisashi
    Sasahara, Masakiyo
    Kuroda, Satoshi
    [J]. JOURNAL OF NEUROSURGERY, 2020, 134 (05) : 1535 - 1543